Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist
A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative c...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SMITH, JULIAN DUNCAN SILK, TERENCE VERNON |
| description | A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative compound and the pharmaceutical uses of such a crystalline form are disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ533053A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ533053A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ533053A3</originalsourceid><addsrcrecordid>eNqFy7EKwjAQgOEuDqK-gtwLCGLo5FRKxcnJyaWc7UUDyV24JIW-vRXcnf7l-9dV3-qcMnrvmMCKBhALCOqeYosiS5p9UWEMbiQYSd2E2U10XtC7BGTAkRb13ZtTA0oDxSwK-BJ2KW-rlUWfaPfrptpfunt7PVCUnlLEgZhyf3vUxhxr05i_4ANKITwG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist</title><source>esp@cenet</source><creator>SMITH, JULIAN DUNCAN ; SILK, TERENCE VERNON</creator><creatorcontrib>SMITH, JULIAN DUNCAN ; SILK, TERENCE VERNON</creatorcontrib><description>A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative compound and the pharmaceutical uses of such a crystalline form are disclosed.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060929&DB=EPODOC&CC=NZ&NR=533053A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060929&DB=EPODOC&CC=NZ&NR=533053A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMITH, JULIAN DUNCAN</creatorcontrib><creatorcontrib>SILK, TERENCE VERNON</creatorcontrib><title>Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist</title><description>A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative compound and the pharmaceutical uses of such a crystalline form are disclosed.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFy7EKwjAQgOEuDqK-gtwLCGLo5FRKxcnJyaWc7UUDyV24JIW-vRXcnf7l-9dV3-qcMnrvmMCKBhALCOqeYosiS5p9UWEMbiQYSd2E2U10XtC7BGTAkRb13ZtTA0oDxSwK-BJ2KW-rlUWfaPfrptpfunt7PVCUnlLEgZhyf3vUxhxr05i_4ANKITwG</recordid><startdate>20060929</startdate><enddate>20060929</enddate><creator>SMITH, JULIAN DUNCAN</creator><creator>SILK, TERENCE VERNON</creator><scope>EVB</scope></search><sort><creationdate>20060929</creationdate><title>Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist</title><author>SMITH, JULIAN DUNCAN ; SILK, TERENCE VERNON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ533053A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>SMITH, JULIAN DUNCAN</creatorcontrib><creatorcontrib>SILK, TERENCE VERNON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMITH, JULIAN DUNCAN</au><au>SILK, TERENCE VERNON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist</title><date>2006-09-29</date><risdate>2006</risdate><abstract>A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative compound and the pharmaceutical uses of such a crystalline form are disclosed.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ533053A |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A23%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMITH,%20JULIAN%20DUNCAN&rft.date=2006-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ533053A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |